Japikse Russell D, Sevenson James E, Pickhardt Perry J, Repplinger Michael D
Department of Emergency Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
WMJ. 2017 Aug;116(3):173-176.
Segmental arterial mediolysis (SAM) is a rare nonatherosclerotic, noninflammatory vasculopathy causing arterial wall necrosis that leads to strictures, dissections, and aneurysms, particularly in medium-sized abdominal arteries. Awareness of SAM is important because, unlike vasculitides, immunosuppressive treatment may worsen the disease process.
A 58-year-old man with multiple medical comorbidities presented with acute epigastric pain and a right incarcerated inguinal hernia that was interpreted as showing bowel strangulation on computed tomography. The hernia was unable to be reduced in the emergency department, so the patient was taken for open reduction by the surgical service. Intraoperatively, he was noted to have a ruptured superior mesenteric artery aneurysm. Conventional angiography demonstrated a bead-like appearance of several jejunal branches of the superior mesenteric artery, raising concern for a vasculitis. His hospital course included rheumatologic consultation, and initial recommendations were to start immunosuppressive therapy for treatment of polyarteritis nodosa. Further testing demonstrated normal antinuclear antibody, antineutrophil cytoplasmic antibodies, and complement levels. Due to a lack of systemic symptoms or signs and otherwise unremarkable laboratory evaluation, the patient ultimately was diagnosed with SAM and immunosuppressive therapy was halted.
Unexplained medium arterial stenosis, dissection, aneurysm, and hemorrhage should raise suspicion for possible SAM. The initial management approach should focus on treatment of the acute hemorrhage, usually involving endovascular stenting or coil embolization. Unlike vasculitides, SAM does not benefit from, and may actually be harmed by, immunosuppressive therapy.
Clinicians involved in the longitudinal care of emergency department patients should be aware of this rare clinical entity in order to initiate appropriate treatment.
节段性动脉中层溶解(SAM)是一种罕见的非动脉粥样硬化、非炎症性血管病变,可导致动脉壁坏死,进而引起狭窄、夹层和动脉瘤,尤其好发于中腹部动脉。了解SAM很重要,因为与血管炎不同,免疫抑制治疗可能会使疾病进程恶化。
一名患有多种内科合并症的58岁男性,因突发上腹部疼痛和右侧腹股沟嵌顿疝就诊,计算机断层扫描显示有肠绞窄。在急诊科无法还纳疝,因此患者被外科收治进行开放复位。术中发现他有肠系膜上动脉动脉瘤破裂。传统血管造影显示肠系膜上动脉的几个空肠分支呈串珠样外观,这引发了对血管炎的担忧。他的住院过程包括风湿科会诊,最初建议开始免疫抑制治疗以治疗结节性多动脉炎。进一步检查显示抗核抗体、抗中性粒细胞胞浆抗体和补体水平正常。由于缺乏全身症状或体征,且实验室检查无其他异常,该患者最终被诊断为SAM,免疫抑制治疗也随之停止。
不明原因的中动脉狭窄、夹层、动脉瘤和出血应引起对可能存在SAM的怀疑。初始治疗方法应侧重于治疗急性出血,通常涉及血管内支架置入或弹簧圈栓塞。与血管炎不同,SAM无法从免疫抑制治疗中获益,实际上可能会受到其伤害。
参与急诊科患者长期护理的临床医生应了解这种罕见的临床实体,以便启动适当的治疗。